Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden
· Delayed Price · Currency is SEK 24.60
+0.30 (1.23%)
Mar 9, 2026, 5:29 PM CET
Xspray Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 153.75 | 208.24 | 166.3 | 120.17 | 271.88 | Upgrade
|
| Cash & Short-Term Investments | 153.75 | 208.24 | 166.3 | 120.17 | 271.88 | Upgrade
|
| Cash Growth | -26.17% | 25.21% | 38.39% | -55.80% | -16.50% | Upgrade
|
| Other Receivables | 3.84 | 4.02 | 4.17 | 2.59 | 2.5 | Upgrade
|
| Receivables | 3.84 | 4.02 | 4.17 | 2.59 | 2.5 | Upgrade
|
| Inventory | 22.3 | 20.34 | 43.78 | 8.55 | 6.2 | Upgrade
|
| Prepaid Expenses | 3.01 | 2.48 | 3.57 | 0.93 | 1.48 | Upgrade
|
| Other Current Assets | 0 | 0 | - | -0 | -0 | Upgrade
|
| Total Current Assets | 182.9 | 235.07 | 217.82 | 132.23 | 282.07 | Upgrade
|
| Property, Plant & Equipment | 70.99 | 79.18 | 107.65 | 64.6 | 44.6 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Long-Term Deferred Charges | 512.19 | 478.93 | 436.78 | 385.6 | 296.24 | Upgrade
|
| Other Long-Term Assets | 3.27 | 3.17 | 3.02 | 3 | - | Upgrade
|
| Total Assets | 769.35 | 796.34 | 765.26 | 585.43 | 622.9 | Upgrade
|
| Accounts Payable | 3.32 | 17.08 | 12.47 | 14.79 | 16.87 | Upgrade
|
| Accrued Expenses | 11.85 | 18.63 | 16.31 | 11.41 | 10.3 | Upgrade
|
| Short-Term Debt | - | 96 | - | - | - | Upgrade
|
| Current Portion of Leases | 5.36 | 5.11 | 4.86 | 1.57 | 2.05 | Upgrade
|
| Other Current Liabilities | 1.13 | 9.31 | 6.26 | 1.09 | 0.75 | Upgrade
|
| Total Current Liabilities | 21.66 | 146.14 | 39.9 | 28.85 | 29.97 | Upgrade
|
| Long-Term Debt | 121.32 | - | - | - | - | Upgrade
|
| Long-Term Leases | 21.72 | 27.11 | 31.95 | 0.56 | 1.19 | Upgrade
|
| Other Long-Term Liabilities | - | -0 | - | - | - | Upgrade
|
| Total Liabilities | 164.7 | 173.25 | 71.85 | 29.41 | 31.15 | Upgrade
|
| Common Stock | 41.74 | 37.14 | 31.25 | 22.68 | 20.68 | Upgrade
|
| Additional Paid-In Capital | 1,574 | 1,425 | 1,216 | 907.42 | 813.48 | Upgrade
|
| Retained Earnings | -1,012 | -840.25 | -554.72 | -374.08 | -242.41 | Upgrade
|
| Comprehensive Income & Other | 0.55 | 1 | 0.79 | - | - | Upgrade
|
| Shareholders' Equity | 604.65 | 623.1 | 693.41 | 556.02 | 591.75 | Upgrade
|
| Total Liabilities & Equity | 769.35 | 796.34 | 765.26 | 585.43 | 622.9 | Upgrade
|
| Total Debt | 148.39 | 128.22 | 36.81 | 2.13 | 3.23 | Upgrade
|
| Net Cash (Debt) | 5.35 | 80.02 | 129.5 | 118.04 | 268.65 | Upgrade
|
| Net Cash Growth | -93.31% | -38.21% | 9.70% | -56.06% | -16.23% | Upgrade
|
| Net Cash Per Share | 0.14 | 2.41 | 4.87 | 5.60 | 13.96 | Upgrade
|
| Filing Date Shares Outstanding | 41.74 | 37.14 | 31.25 | 22.68 | 20.68 | Upgrade
|
| Total Common Shares Outstanding | 41.74 | 37.14 | 31.25 | 22.68 | 20.68 | Upgrade
|
| Working Capital | 161.23 | 88.93 | 177.91 | 103.38 | 252.1 | Upgrade
|
| Book Value Per Share | 14.49 | 16.78 | 22.19 | 24.52 | 28.61 | Upgrade
|
| Tangible Book Value | 604.65 | 623.1 | 693.41 | 556.02 | 591.75 | Upgrade
|
| Tangible Book Value Per Share | 14.49 | 16.78 | 22.19 | 24.52 | 28.61 | Upgrade
|
| Machinery | - | 51.5 | 52.12 | 49.82 | 46.96 | Upgrade
|
| Construction In Progress | - | 41.39 | 59.37 | 46.57 | 20.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.